Global AI-driven Peptide Drug Discovery Platform Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global AI-driven Peptide Drug Discovery Platform market size will reach USD 1347 million in 2031, growing at a CAGR of 9.0% over the analysis period.
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schr?dinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's '14th Five-Year Plan for Bioeconomic Development' policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.
This report is a detailed and comprehensive analysis for global AI-driven Peptide Drug Discovery Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-driven Peptide Drug Discovery Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-driven Peptide Drug Discovery Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI, Insilico Medicine, Schr?dinger, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI-driven Peptide Drug Discovery Platform market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI-driven Peptide Drug Discovery Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-driven Peptide Drug Discovery Platform, with revenue, gross margin, and global market share of AI-driven Peptide Drug Discovery Platform from 2020 to 2025.
Chapter 3, the AI-driven Peptide Drug Discovery Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI-driven Peptide Drug Discovery Platform market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-driven Peptide Drug Discovery Platform.
Chapter 13, to describe AI-driven Peptide Drug Discovery Platform research findings and conclusion.
AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schr?dinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's '14th Five-Year Plan for Bioeconomic Development' policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.
This report is a detailed and comprehensive analysis for global AI-driven Peptide Drug Discovery Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI-driven Peptide Drug Discovery Platform market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-driven Peptide Drug Discovery Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-driven Peptide Drug Discovery Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI, Insilico Medicine, Schr?dinger, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI-driven Peptide Drug Discovery Platform market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Design and Generation Platform
- Screening and Optimization Platform
- Data-driven Platform
- Others
- Scientific Research
- Pharmaceuticals
- Peptilogics
- Pepticom Ltd
- Menten AI
- GUBRA
- Creative Peptides
- Exscalate
- Generate Biomedicines
- Receptor.AI
- Insilico Medicine
- Schr?dinger
- BenevolentAI
- Evotec
- PeptiFinder
- Xtalpi
- Sun Novo
- Zonsen Peplib Biotech
- Tide Tron Biotech
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI-driven Peptide Drug Discovery Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-driven Peptide Drug Discovery Platform, with revenue, gross margin, and global market share of AI-driven Peptide Drug Discovery Platform from 2020 to 2025.
Chapter 3, the AI-driven Peptide Drug Discovery Platform competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI-driven Peptide Drug Discovery Platform market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-driven Peptide Drug Discovery Platform.
Chapter 13, to describe AI-driven Peptide Drug Discovery Platform research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-driven Peptide Drug Discovery Platform by Type
1.3.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type in 2024
1.3.3 Design and Generation Platform
1.3.4 Screening and Optimization Platform
1.3.5 Data-driven Platform
1.3.6 Others
1.4 Global AI-driven Peptide Drug Discovery Platform Market by Application
1.4.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Scientific Research
1.4.3 Pharmaceuticals
1.5 Global AI-driven Peptide Drug Discovery Platform Market Size & Forecast
1.6 Global AI-driven Peptide Drug Discovery Platform Market Size and Forecast by Region
1.6.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Region, (2020-2031)
1.6.3 North America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.4 Europe AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.6 South America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Peptilogics
2.1.1 Peptilogics Details
2.1.2 Peptilogics Major Business
2.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Product and Solutions
2.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Peptilogics Recent Developments and Future Plans
2.2 Pepticom Ltd
2.2.1 Pepticom Ltd Details
2.2.2 Pepticom Ltd Major Business
2.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product and Solutions
2.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pepticom Ltd Recent Developments and Future Plans
2.3 Menten AI
2.3.1 Menten AI Details
2.3.2 Menten AI Major Business
2.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Menten AI Recent Developments and Future Plans
2.4 GUBRA
2.4.1 GUBRA Details
2.4.2 GUBRA Major Business
2.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Product and Solutions
2.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 GUBRA Recent Developments and Future Plans
2.5 Creative Peptides
2.5.1 Creative Peptides Details
2.5.2 Creative Peptides Major Business
2.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Product and Solutions
2.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Creative Peptides Recent Developments and Future Plans
2.6 Exscalate
2.6.1 Exscalate Details
2.6.2 Exscalate Major Business
2.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Product and Solutions
2.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Exscalate Recent Developments and Future Plans
2.7 Generate Biomedicines
2.7.1 Generate Biomedicines Details
2.7.2 Generate Biomedicines Major Business
2.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product and Solutions
2.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Generate Biomedicines Recent Developments and Future Plans
2.8 Receptor.AI
2.8.1 Receptor.AI Details
2.8.2 Receptor.AI Major Business
2.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Receptor.AI Recent Developments and Future Plans
2.9 Insilico Medicine
2.9.1 Insilico Medicine Details
2.9.2 Insilico Medicine Major Business
2.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product and Solutions
2.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Insilico Medicine Recent Developments and Future Plans
2.10 Schr?dinger
2.10.1 Schr?dinger Details
2.10.2 Schr?dinger Major Business
2.10.3 Schr?dinger AI-driven Peptide Drug Discovery Platform Product and Solutions
2.10.4 Schr?dinger AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Schr?dinger Recent Developments and Future Plans
2.11 BenevolentAI
2.11.1 BenevolentAI Details
2.11.2 BenevolentAI Major Business
2.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BenevolentAI Recent Developments and Future Plans
2.12 Evotec
2.12.1 Evotec Details
2.12.2 Evotec Major Business
2.12.3 Evotec AI-driven Peptide Drug Discovery Platform Product and Solutions
2.12.4 Evotec AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Evotec Recent Developments and Future Plans
2.13 PeptiFinder
2.13.1 PeptiFinder Details
2.13.2 PeptiFinder Major Business
2.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Product and Solutions
2.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 PeptiFinder Recent Developments and Future Plans
2.14 Xtalpi
2.14.1 Xtalpi Details
2.14.2 Xtalpi Major Business
2.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Product and Solutions
2.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Xtalpi Recent Developments and Future Plans
2.15 Sun Novo
2.15.1 Sun Novo Details
2.15.2 Sun Novo Major Business
2.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Product and Solutions
2.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Sun Novo Recent Developments and Future Plans
2.16 Zonsen Peplib Biotech
2.16.1 Zonsen Peplib Biotech Details
2.16.2 Zonsen Peplib Biotech Major Business
2.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
2.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Zonsen Peplib Biotech Recent Developments and Future Plans
2.17 Tide Tron Biotech
2.17.1 Tide Tron Biotech Details
2.17.2 Tide Tron Biotech Major Business
2.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
2.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Tide Tron Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-driven Peptide Drug Discovery Platform Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI-driven Peptide Drug Discovery Platform by Company Revenue
3.2.2 Top 3 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
3.2.3 Top 6 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
3.3 AI-driven Peptide Drug Discovery Platform Market: Overall Company Footprint Analysis
3.3.1 AI-driven Peptide Drug Discovery Platform Market: Region Footprint
3.3.2 AI-driven Peptide Drug Discovery Platform Market: Company Product Type Footprint
3.3.3 AI-driven Peptide Drug Discovery Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2025)
5.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
6.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country
6.3.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
6.3.2 United States AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
6.3.3 Canada AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
6.3.4 Mexico AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
7.2 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country
7.3.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
7.3.2 Germany AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.3 France AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.5 Russia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.6 Italy AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region
8.3.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2031)
8.3.2 China AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.3 Japan AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.4 South Korea AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.5 India AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.7 Australia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
9.2 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
9.3 South America AI-driven Peptide Drug Discovery Platform Market Size by Country
9.3.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
9.3.2 Brazil AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
9.3.3 Argentina AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country
10.3.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
10.3.2 Turkey AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10.3.4 UAE AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI-driven Peptide Drug Discovery Platform Market Drivers
11.2 AI-driven Peptide Drug Discovery Platform Market Restraints
11.3 AI-driven Peptide Drug Discovery Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-driven Peptide Drug Discovery Platform Industry Chain
12.2 AI-driven Peptide Drug Discovery Platform Upstream Analysis
12.3 AI-driven Peptide Drug Discovery Platform Midstream Analysis
12.4 AI-driven Peptide Drug Discovery Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-driven Peptide Drug Discovery Platform by Type
1.3.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type in 2024
1.3.3 Design and Generation Platform
1.3.4 Screening and Optimization Platform
1.3.5 Data-driven Platform
1.3.6 Others
1.4 Global AI-driven Peptide Drug Discovery Platform Market by Application
1.4.1 Overview: Global AI-driven Peptide Drug Discovery Platform Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Scientific Research
1.4.3 Pharmaceuticals
1.5 Global AI-driven Peptide Drug Discovery Platform Market Size & Forecast
1.6 Global AI-driven Peptide Drug Discovery Platform Market Size and Forecast by Region
1.6.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Region, (2020-2031)
1.6.3 North America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.4 Europe AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.6 South America AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Peptilogics
2.1.1 Peptilogics Details
2.1.2 Peptilogics Major Business
2.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Product and Solutions
2.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Peptilogics Recent Developments and Future Plans
2.2 Pepticom Ltd
2.2.1 Pepticom Ltd Details
2.2.2 Pepticom Ltd Major Business
2.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product and Solutions
2.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pepticom Ltd Recent Developments and Future Plans
2.3 Menten AI
2.3.1 Menten AI Details
2.3.2 Menten AI Major Business
2.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Menten AI Recent Developments and Future Plans
2.4 GUBRA
2.4.1 GUBRA Details
2.4.2 GUBRA Major Business
2.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Product and Solutions
2.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 GUBRA Recent Developments and Future Plans
2.5 Creative Peptides
2.5.1 Creative Peptides Details
2.5.2 Creative Peptides Major Business
2.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Product and Solutions
2.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Creative Peptides Recent Developments and Future Plans
2.6 Exscalate
2.6.1 Exscalate Details
2.6.2 Exscalate Major Business
2.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Product and Solutions
2.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Exscalate Recent Developments and Future Plans
2.7 Generate Biomedicines
2.7.1 Generate Biomedicines Details
2.7.2 Generate Biomedicines Major Business
2.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product and Solutions
2.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Generate Biomedicines Recent Developments and Future Plans
2.8 Receptor.AI
2.8.1 Receptor.AI Details
2.8.2 Receptor.AI Major Business
2.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Receptor.AI Recent Developments and Future Plans
2.9 Insilico Medicine
2.9.1 Insilico Medicine Details
2.9.2 Insilico Medicine Major Business
2.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product and Solutions
2.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Insilico Medicine Recent Developments and Future Plans
2.10 Schr?dinger
2.10.1 Schr?dinger Details
2.10.2 Schr?dinger Major Business
2.10.3 Schr?dinger AI-driven Peptide Drug Discovery Platform Product and Solutions
2.10.4 Schr?dinger AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Schr?dinger Recent Developments and Future Plans
2.11 BenevolentAI
2.11.1 BenevolentAI Details
2.11.2 BenevolentAI Major Business
2.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Product and Solutions
2.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BenevolentAI Recent Developments and Future Plans
2.12 Evotec
2.12.1 Evotec Details
2.12.2 Evotec Major Business
2.12.3 Evotec AI-driven Peptide Drug Discovery Platform Product and Solutions
2.12.4 Evotec AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Evotec Recent Developments and Future Plans
2.13 PeptiFinder
2.13.1 PeptiFinder Details
2.13.2 PeptiFinder Major Business
2.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Product and Solutions
2.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 PeptiFinder Recent Developments and Future Plans
2.14 Xtalpi
2.14.1 Xtalpi Details
2.14.2 Xtalpi Major Business
2.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Product and Solutions
2.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Xtalpi Recent Developments and Future Plans
2.15 Sun Novo
2.15.1 Sun Novo Details
2.15.2 Sun Novo Major Business
2.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Product and Solutions
2.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Sun Novo Recent Developments and Future Plans
2.16 Zonsen Peplib Biotech
2.16.1 Zonsen Peplib Biotech Details
2.16.2 Zonsen Peplib Biotech Major Business
2.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
2.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Zonsen Peplib Biotech Recent Developments and Future Plans
2.17 Tide Tron Biotech
2.17.1 Tide Tron Biotech Details
2.17.2 Tide Tron Biotech Major Business
2.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
2.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Tide Tron Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-driven Peptide Drug Discovery Platform Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI-driven Peptide Drug Discovery Platform by Company Revenue
3.2.2 Top 3 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
3.2.3 Top 6 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
3.3 AI-driven Peptide Drug Discovery Platform Market: Overall Company Footprint Analysis
3.3.1 AI-driven Peptide Drug Discovery Platform Market: Region Footprint
3.3.2 AI-driven Peptide Drug Discovery Platform Market: Company Product Type Footprint
3.3.3 AI-driven Peptide Drug Discovery Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2025)
5.2 Global AI-driven Peptide Drug Discovery Platform Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
6.2 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)
6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country
6.3.1 North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
6.3.2 United States AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
6.3.3 Canada AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
6.3.4 Mexico AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
7.2 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country
7.3.1 Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
7.3.2 Germany AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.3 France AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.5 Russia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
7.3.6 Italy AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region
8.3.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2031)
8.3.2 China AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.3 Japan AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.4 South Korea AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.5 India AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
8.3.7 Australia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
9.2 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
9.3 South America AI-driven Peptide Drug Discovery Platform Market Size by Country
9.3.1 South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
9.3.2 Brazil AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
9.3.3 Argentina AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country
10.3.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2031)
10.3.2 Turkey AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
10.3.4 UAE AI-driven Peptide Drug Discovery Platform Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI-driven Peptide Drug Discovery Platform Market Drivers
11.2 AI-driven Peptide Drug Discovery Platform Market Restraints
11.3 AI-driven Peptide Drug Discovery Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-driven Peptide Drug Discovery Platform Industry Chain
12.2 AI-driven Peptide Drug Discovery Platform Upstream Analysis
12.3 AI-driven Peptide Drug Discovery Platform Midstream Analysis
12.4 AI-driven Peptide Drug Discovery Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Peptilogics Company Information, Head Office, and Major Competitors
Table 6. Peptilogics Major Business
Table 7. Peptilogics AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 8. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Peptilogics Recent Developments and Future Plans
Table 10. Pepticom Ltd Company Information, Head Office, and Major Competitors
Table 11. Pepticom Ltd Major Business
Table 12. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 13. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Pepticom Ltd Recent Developments and Future Plans
Table 15. Menten AI Company Information, Head Office, and Major Competitors
Table 16. Menten AI Major Business
Table 17. Menten AI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 18. Menten AI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. GUBRA Company Information, Head Office, and Major Competitors
Table 20. GUBRA Major Business
Table 21. GUBRA AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 22. GUBRA AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. GUBRA Recent Developments and Future Plans
Table 24. Creative Peptides Company Information, Head Office, and Major Competitors
Table 25. Creative Peptides Major Business
Table 26. Creative Peptides AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 27. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Creative Peptides Recent Developments and Future Plans
Table 29. Exscalate Company Information, Head Office, and Major Competitors
Table 30. Exscalate Major Business
Table 31. Exscalate AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 32. Exscalate AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Exscalate Recent Developments and Future Plans
Table 34. Generate Biomedicines Company Information, Head Office, and Major Competitors
Table 35. Generate Biomedicines Major Business
Table 36. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 37. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Generate Biomedicines Recent Developments and Future Plans
Table 39. Receptor.AI Company Information, Head Office, and Major Competitors
Table 40. Receptor.AI Major Business
Table 41. Receptor.AI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 42. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Receptor.AI Recent Developments and Future Plans
Table 44. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 45. Insilico Medicine Major Business
Table 46. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 47. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Insilico Medicine Recent Developments and Future Plans
Table 49. Schr?dinger Company Information, Head Office, and Major Competitors
Table 50. Schr?dinger Major Business
Table 51. Schr?dinger AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 52. Schr?dinger AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Schr?dinger Recent Developments and Future Plans
Table 54. BenevolentAI Company Information, Head Office, and Major Competitors
Table 55. BenevolentAI Major Business
Table 56. BenevolentAI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 57. BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. BenevolentAI Recent Developments and Future Plans
Table 59. Evotec Company Information, Head Office, and Major Competitors
Table 60. Evotec Major Business
Table 61. Evotec AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 62. Evotec AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Evotec Recent Developments and Future Plans
Table 64. PeptiFinder Company Information, Head Office, and Major Competitors
Table 65. PeptiFinder Major Business
Table 66. PeptiFinder AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 67. PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. PeptiFinder Recent Developments and Future Plans
Table 69. Xtalpi Company Information, Head Office, and Major Competitors
Table 70. Xtalpi Major Business
Table 71. Xtalpi AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 72. Xtalpi AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Xtalpi Recent Developments and Future Plans
Table 74. Sun Novo Company Information, Head Office, and Major Competitors
Table 75. Sun Novo Major Business
Table 76. Sun Novo AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 77. Sun Novo AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Sun Novo Recent Developments and Future Plans
Table 79. Zonsen Peplib Biotech Company Information, Head Office, and Major Competitors
Table 80. Zonsen Peplib Biotech Major Business
Table 81. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 82. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Zonsen Peplib Biotech Recent Developments and Future Plans
Table 84. Tide Tron Biotech Company Information, Head Office, and Major Competitors
Table 85. Tide Tron Biotech Major Business
Table 86. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 87. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Tide Tron Biotech Recent Developments and Future Plans
Table 89. Global AI-driven Peptide Drug Discovery Platform Revenue (USD Million) by Players (2020-2025)
Table 90. Global AI-driven Peptide Drug Discovery Platform Revenue Share by Players (2020-2025)
Table 91. Breakdown of AI-driven Peptide Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in AI-driven Peptide Drug Discovery Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key AI-driven Peptide Drug Discovery Platform Players
Table 94. AI-driven Peptide Drug Discovery Platform Market: Company Product Type Footprint
Table 95. AI-driven Peptide Drug Discovery Platform Market: Company Product Application Footprint
Table 96. AI-driven Peptide Drug Discovery Platform New Market Entrants and Barriers to Market Entry
Table 97. AI-driven Peptide Drug Discovery Platform Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global AI-driven Peptide Drug Discovery Platform Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Type (2020-2025)
Table 100. Global AI-driven Peptide Drug Discovery Platform Consumption Value Forecast by Type (2026-2031)
Table 101. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025)
Table 102. Global AI-driven Peptide Drug Discovery Platform Consumption Value Forecast by Application (2026-2031)
Table 103. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of AI-driven Peptide Drug Discovery Platform Upstream (Raw Materials)
Table 134. Global AI-driven Peptide Drug Discovery Platform Typical Customers
Table 1. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Peptilogics Company Information, Head Office, and Major Competitors
Table 6. Peptilogics Major Business
Table 7. Peptilogics AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 8. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Peptilogics Recent Developments and Future Plans
Table 10. Pepticom Ltd Company Information, Head Office, and Major Competitors
Table 11. Pepticom Ltd Major Business
Table 12. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 13. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Pepticom Ltd Recent Developments and Future Plans
Table 15. Menten AI Company Information, Head Office, and Major Competitors
Table 16. Menten AI Major Business
Table 17. Menten AI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 18. Menten AI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. GUBRA Company Information, Head Office, and Major Competitors
Table 20. GUBRA Major Business
Table 21. GUBRA AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 22. GUBRA AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. GUBRA Recent Developments and Future Plans
Table 24. Creative Peptides Company Information, Head Office, and Major Competitors
Table 25. Creative Peptides Major Business
Table 26. Creative Peptides AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 27. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Creative Peptides Recent Developments and Future Plans
Table 29. Exscalate Company Information, Head Office, and Major Competitors
Table 30. Exscalate Major Business
Table 31. Exscalate AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 32. Exscalate AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Exscalate Recent Developments and Future Plans
Table 34. Generate Biomedicines Company Information, Head Office, and Major Competitors
Table 35. Generate Biomedicines Major Business
Table 36. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 37. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Generate Biomedicines Recent Developments and Future Plans
Table 39. Receptor.AI Company Information, Head Office, and Major Competitors
Table 40. Receptor.AI Major Business
Table 41. Receptor.AI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 42. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Receptor.AI Recent Developments and Future Plans
Table 44. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 45. Insilico Medicine Major Business
Table 46. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 47. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Insilico Medicine Recent Developments and Future Plans
Table 49. Schr?dinger Company Information, Head Office, and Major Competitors
Table 50. Schr?dinger Major Business
Table 51. Schr?dinger AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 52. Schr?dinger AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Schr?dinger Recent Developments and Future Plans
Table 54. BenevolentAI Company Information, Head Office, and Major Competitors
Table 55. BenevolentAI Major Business
Table 56. BenevolentAI AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 57. BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. BenevolentAI Recent Developments and Future Plans
Table 59. Evotec Company Information, Head Office, and Major Competitors
Table 60. Evotec Major Business
Table 61. Evotec AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 62. Evotec AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Evotec Recent Developments and Future Plans
Table 64. PeptiFinder Company Information, Head Office, and Major Competitors
Table 65. PeptiFinder Major Business
Table 66. PeptiFinder AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 67. PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. PeptiFinder Recent Developments and Future Plans
Table 69. Xtalpi Company Information, Head Office, and Major Competitors
Table 70. Xtalpi Major Business
Table 71. Xtalpi AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 72. Xtalpi AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Xtalpi Recent Developments and Future Plans
Table 74. Sun Novo Company Information, Head Office, and Major Competitors
Table 75. Sun Novo Major Business
Table 76. Sun Novo AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 77. Sun Novo AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Sun Novo Recent Developments and Future Plans
Table 79. Zonsen Peplib Biotech Company Information, Head Office, and Major Competitors
Table 80. Zonsen Peplib Biotech Major Business
Table 81. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 82. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Zonsen Peplib Biotech Recent Developments and Future Plans
Table 84. Tide Tron Biotech Company Information, Head Office, and Major Competitors
Table 85. Tide Tron Biotech Major Business
Table 86. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product and Solutions
Table 87. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Tide Tron Biotech Recent Developments and Future Plans
Table 89. Global AI-driven Peptide Drug Discovery Platform Revenue (USD Million) by Players (2020-2025)
Table 90. Global AI-driven Peptide Drug Discovery Platform Revenue Share by Players (2020-2025)
Table 91. Breakdown of AI-driven Peptide Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in AI-driven Peptide Drug Discovery Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key AI-driven Peptide Drug Discovery Platform Players
Table 94. AI-driven Peptide Drug Discovery Platform Market: Company Product Type Footprint
Table 95. AI-driven Peptide Drug Discovery Platform Market: Company Product Application Footprint
Table 96. AI-driven Peptide Drug Discovery Platform New Market Entrants and Barriers to Market Entry
Table 97. AI-driven Peptide Drug Discovery Platform Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global AI-driven Peptide Drug Discovery Platform Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Type (2020-2025)
Table 100. Global AI-driven Peptide Drug Discovery Platform Consumption Value Forecast by Type (2026-2031)
Table 101. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025)
Table 102. Global AI-driven Peptide Drug Discovery Platform Consumption Value Forecast by Application (2026-2031)
Table 103. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of AI-driven Peptide Drug Discovery Platform Upstream (Raw Materials)
Table 134. Global AI-driven Peptide Drug Discovery Platform Typical Customers
LIST OF FIGURES
Figure 1. AI-driven Peptide Drug Discovery Platform Picture
Figure 2. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type in 2024
Figure 4. Design and Generation Platform
Figure 5. Screening and Optimization Platform
Figure 6. Data-driven Platform
Figure 7. Others
Figure 8. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application in 2024
Figure 10. Scientific Research Picture
Figure 11. Pharmaceuticals Picture
Figure 12. Global AI-driven Peptide Drug Discovery Platform Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global AI-driven Peptide Drug Discovery Platform Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market AI-driven Peptide Drug Discovery Platform Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region (2020-2031)
Figure 16. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region in 2024
Figure 17. North America AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 20. South America AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global AI-driven Peptide Drug Discovery Platform Revenue Share by Players in 2024
Figure 24. AI-driven Peptide Drug Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of AI-driven Peptide Drug Discovery Platform by Player Revenue in 2024
Figure 26. Top 3 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
Figure 27. Top 6 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
Figure 28. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Type (2020-2025)
Figure 29. Global AI-driven Peptide Drug Discovery Platform Market Share Forecast by Type (2026-2031)
Figure 30. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Application (2020-2025)
Figure 31. Global AI-driven Peptide Drug Discovery Platform Market Share Forecast by Application (2026-2031)
Figure 32. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 33. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 34. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 35. United States AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 42. France AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region (2020-2031)
Figure 49. China AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 52. India AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 55. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 56. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 57. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 66. AI-driven Peptide Drug Discovery Platform Market Drivers
Figure 67. AI-driven Peptide Drug Discovery Platform Market Restraints
Figure 68. AI-driven Peptide Drug Discovery Platform Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. AI-driven Peptide Drug Discovery Platform Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. AI-driven Peptide Drug Discovery Platform Picture
Figure 2. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type in 2024
Figure 4. Design and Generation Platform
Figure 5. Screening and Optimization Platform
Figure 6. Data-driven Platform
Figure 7. Others
Figure 8. Global AI-driven Peptide Drug Discovery Platform Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application in 2024
Figure 10. Scientific Research Picture
Figure 11. Pharmaceuticals Picture
Figure 12. Global AI-driven Peptide Drug Discovery Platform Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global AI-driven Peptide Drug Discovery Platform Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market AI-driven Peptide Drug Discovery Platform Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region (2020-2031)
Figure 16. Global AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region in 2024
Figure 17. North America AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 20. South America AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global AI-driven Peptide Drug Discovery Platform Revenue Share by Players in 2024
Figure 24. AI-driven Peptide Drug Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of AI-driven Peptide Drug Discovery Platform by Player Revenue in 2024
Figure 26. Top 3 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
Figure 27. Top 6 AI-driven Peptide Drug Discovery Platform Players Market Share in 2024
Figure 28. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Type (2020-2025)
Figure 29. Global AI-driven Peptide Drug Discovery Platform Market Share Forecast by Type (2026-2031)
Figure 30. Global AI-driven Peptide Drug Discovery Platform Consumption Value Share by Application (2020-2025)
Figure 31. Global AI-driven Peptide Drug Discovery Platform Market Share Forecast by Application (2026-2031)
Figure 32. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 33. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 34. North America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 35. United States AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 42. France AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Region (2020-2031)
Figure 49. China AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 52. India AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 55. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 56. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 57. South America AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa AI-driven Peptide Drug Discovery Platform Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE AI-driven Peptide Drug Discovery Platform Consumption Value (2020-2031) & (USD Million)
Figure 66. AI-driven Peptide Drug Discovery Platform Market Drivers
Figure 67. AI-driven Peptide Drug Discovery Platform Market Restraints
Figure 68. AI-driven Peptide Drug Discovery Platform Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. AI-driven Peptide Drug Discovery Platform Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
